Antipsychotic Can Allegedly Cause Patients to Develop Diabetes

Eli Lilly & Co., the manufacturer of Zyprexa, is once again facing accusations regarding side effects associated with one of its best-selling medications.

Zyprexa (olanzapine), an 'atypical antipsychotic,' has been implicated in a growing number of product liability suits filed by patients who allegedly developed hyperglycemia, diabetes or ketoacidosis after using the drug.

photo-4

The actions claim that Lilly employed aggressive marketing tactics while promoting the drug that included encouraging physicians to prescribe Zyprexa for off-label uses such as the treatment of post-traumatic stress disorder.

Zyprexa received approval from the FDA in 1996 for the treatment of schizophrenia …